Pharma Journalist - Page 841 of 957 -

Cognizant Extends Gilead Partnership to Expand AI-Enabled DevOps

CSL, Alentis Partner on $1.55B Kidney and Liver Drug

Alector Licenses Parkinson’s Drug Program to Genentech for $1.27B

X-Chem extends drug discovery collaboration with AstraZeneca

Eiger Biopharmaceuticals disappointed over negative results of Phase 2 LIBERTY study in PAH

Marina Biotech enters into agreement with Autotelic Bio for developing Marina’s IT-103 Clinical program

FDA grants priority review for Novartis Kymriah for treating r/r DLBCL

OBI Pharma confirms FDA’s clearance of IND for Phase 1 Study of Monoclonal Antibody Cancer Immunotherapy

BioLineRx declares partial results for BL-8040’s Phase 2a COMBAT study

Neurim Pharmaceuticals grants rights to BIOCODEX to market Neurim’s PedPRM